Clinical Trial Update: Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control [Phase 4]

View source ↗

Summary

A randomized Phase 4 trial comparing diltiazem with metoprolol for rate control in atrial fibrillation and atrial flutter; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Diltiazem (diltiazem)
• METOPROLOL (METOPROLOL TARTRATE)

Snippet

Sponsor: CAMC Health System | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 4 | Status: UNKNOWN